These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 356915)

  • 21. [Paroxysmal nocturnal hemoglobinuria (PNH) as a hematopoietic stem cell disorder--long-term support of hematopoiesis by a single stem cell clone in patients with PNH].
    Hirota T
    Rinsho Ketsueki; 2002 Apr; 43(4):215-22. PubMed ID: 12043194
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
    Moore JG; Humphries RK; Frank MM; Young N
    Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria.
    Rotoli B; Robledo R; Scarpato N; Luzzatto L
    Blood; 1984 Oct; 64(4):847-51. PubMed ID: 6478058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 25. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
    Rouault TA; Rosse WF; Bell S; Shelburne J
    Blood; 1978 Feb; 51(2):325-30. PubMed ID: 620087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis.
    Rosse WF; Dourmashkin R; Humphrey JH
    J Exp Med; 1966 Jun; 123(6):969-84. PubMed ID: 5941785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations.
    Madkaikar M; Gupta M; Jijina F; Ghosh K
    Eur J Haematol; 2009 Dec; 83(6):503-11. PubMed ID: 19686268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
    Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
    Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
    Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
    Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A reference guide for paroxysmal nocturnal hemoglobinuria: recent updates and points of medical treatment].
    Gotoh A
    Rinsho Ketsueki; 2020; 61(9):1080-1088. PubMed ID: 33162502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Fredrick LR; Bernshaw NJ; Wilcox LA; Parker CJ
    J Clin Invest; 1989 Jul; 84(1):7-17. PubMed ID: 2738160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
    van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
    Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decay-accelerating-factor-deficient erythrocytes during the long-term clinical course of patients with paroxysmal nocturnal hemoglobinuria.
    Mahbub B; Nishimura J; Kitani T; Kitano K
    Acta Haematol; 1995; 93(2-4):91-7. PubMed ID: 7543722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane.
    Chow FL; Telen MJ; Rosse WF
    Blood; 1985 Oct; 66(4):940-5. PubMed ID: 4041621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.